Industrial Antidotes Key to Toxic Poisoning
In Jan 2019, Covered by
Dr. Piyush Gupta, Director of GNH India Pharmaceuticals Ltd. said “The rise in the demand for these antidotes has a direct correlation with the substantive increase in industrialisation and urbanisation. While most states have put a heavy foot on accelerating these development projects; little to nothing is being done with regard to the human cost”.
5 Challenges in Dealing With a War-Torn Country
In Dec 2018, Covered by
Dr. Piyush Gupta, Director of GNH India Pharmaceuticals Ltd. says, One of the major hurdles is that communication is clogged. There are only some ways to connect to these countries and those too are intermittent which is not quite favourable for the trade activities.
Challenges of pharma industry in exports and distribution
In Dec 2018, Covered by
Dr. Piyush Gupta, Director of GNH India Pharmaceuticals Ltd. says, INDIA is one of the largest providers of generic drugs all across the globe. Along with holding a strong position in the pharmaceutical market worldwide, India also fulfills the need for global supply for different vaccines, supply of antiretroviral drugs combat AIDS (Acquired Immune Deficiency […]
GNH India Completes 200 Successful Audits
In Sep 2018, Covered by
GNH India Pharmaceuticals Ltd., has completed 200 successful audits with its last audit conducted from USA. On this achievement, Dr. Piyush Gupta, Director, GNH India, remarked, “Audits stand as a medium to ascertain the validity and reliability of the information and details claimed by an organization. GNH India has always proven to hold its flag high when […]